| Diabetes-induced microvascular complications at the level of the spinal cord; a contributing factor in diabetic neuropathic pain. | 10.1113/jp275067 | 2018-05 |
| The physiological functions of central nervous system pericytes and a potential role in pain [version 1; referees: 2 approved] | 10.12688/f1000research.13548.1 | 2018-03-20 |
| A role for pericytes in chronic pain? | 10.1097/spc.0000000000000342 | 2018-03 |
| VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis. | 10.1016/j.bbi.2018.03.012 | 2018-03 |
| Physiological role of vascular endothelial growth factors as homeostatic regulators | 10.1002/cphy.c170015 | 2018 |
| Sensory neuronal sensitisation occurs through HMGB-1-RAGE and TRPV1 in high-glucose conditions | 10.1242/jcs.215939 | 2018 |
| Alternative RNA splicing: contribution to pain and potential therapeutic strategy. | 10.1016/j.drudis.2016.06.017 | 2016-11 |
| Alternative RNA splicing: contribution to pain and potential therapeutic strategy- accepted for publication | No DOI available. | 2016 |
| Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration. | 10.1042/CS20150124 | 2015-10 |
| Novel mechanisms of resistance to vemurafenib in melanoma - V600E B-Raf reversion and switching VEGF-A splice isoform expression | No DOI available. | 2015 |
| Novel mechanisms of resistance to vemurafenib in melanoma - V600E B-Raf reversion and switching VEGF-A splice isoform expression. | No DOI available. | 2015 |
| Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia. | 10.1016/j.nbd.2014.08.012 | 2014-11 |
| VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro. | 10.1016/j.ajpath.2013.05.031 | 2013-09 |
| VEGF-A165b is cytoprotective and antiangiogenic in the retina. | 10.1167/iovs.09-4296 | 2010-08 |